Neoadjuvant chemoradiotherapy followed by active surveillance versus standard surgery for oesophageal cancer (SANO trial): a multicentre, stepped-wedge, cluster-randomised, non-inferiority, phase 3 trialBerend J. van der Wilk, Bo Jan Noordman, Maria J. Valkema et al.|The Lancet Oncology|2025Cited by 95
Active surveillance of oesophageal cancer after response to neoadjuvant chemoradiotherapy: dysphagia is uncommonMaria J. Valkema, J. Jan B. van Lanschot, Manon C.W. Spaander et al.|British journal of surgery|2023Cited by 8
796. P02.05 NEOADJUVANT CHEMORADIOTHERAPY FOLLOWED BY ACTIVE SURVEILLANCE VERSUS STANDARD SURGERY FOR OESOPHAGEAL CANCER (SANO-TRIAL): A MULTICENTRE STEPPED-WEDGE CLUSTER-RANDOMISED NONINFERIORITY TRIALBerend Van Der Wilk, J. Jan B. van Lanschot, Ben M. Eyck et al.|Diseases of the Esophagus|2024Cited by 1